Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt

被引:37
作者
Nagy, Mohamed [1 ]
Lynch, Meghan [2 ]
Kamal, Sherif [1 ]
Mohamed, Sarah [1 ]
Hadad, Alaa [1 ]
Abouelnaga, Sherif [1 ]
Aquilante, Christina L. [2 ]
机构
[1] Childrens Canc Hosp Egypt, Cairo 57357, Egypt
[2] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA
关键词
attitude; developing country; knowledge; perception; pharmacogenetics; pharmacogenomics;
D O I
10.2217/pme-2019-0163
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: We evaluated healthcare practitioners' perspectives regarding clinical pharmacogenetics in Cairo, Egypt. Materials & methods: We administered a paper-based survey to pharmacists and physicians practicing at Children's Cancer Hospital Egypt. The survey assessed practitioners' knowledge, attitudes, and perspectives about pharmacogenetic testing. Results: The study included 184 respondents (67.9% pharmacists; 32.1% physicians. Overall, the pharmacogenetic knowledge was low (mean = 41.7%) but attitudes toward pharmacogenetic testing and its potential clinical application were generally positive. Pharmacists responded more favorably than physicians to statements attributing the responsibility of applying pharmacogenetics in the clinical setting to their profession. However, several challenges were identified; the most common being: lack of pharmacogenetic knowledge and skill, lack of pharmacogenetic testing devices, and limited funding. Conclusion: Future efforts to promote pharmacogenetic implementation should focus on foundational education, practical training, and exploration of potential funding sources.
引用
收藏
页码:251 / 260
页数:10
相关论文
共 51 条
[1]   Ethiopian health care professionals' knowledge, attitude, and interests toward pharmacogenomics [J].
Abdela, Ousman Abubeker ;
Bhagavathula, Akshaya Srikanth ;
Gebreyohannes, Eyob Alemayehu ;
Tegegn, Henok Getachew .
PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2017, 10 :279-285
[2]   Implementation and obstacles of pharmacogenetics in clinical practice: An international survey [J].
Abou Diwan, Elizabeth ;
Zeitoun, Ralph I. ;
Abou Haidar, Lea ;
Cascorbi, Ingolf ;
Zgheib, Nathalie Khoueiry .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (09) :2076-2088
[3]   Individualized medicine enabled by genomics in Saudi Arabia [J].
Abu-Elmagd, Muhammad ;
Assidi, Mourad ;
Schulten, Hans-Juergen ;
Dallol, Ashraf ;
Pushparaj, Peter Natesan ;
Ahmed, Farid ;
Scherer, Stephen W. ;
Al-Qahtani, Mohammed .
BMC MEDICAL GENOMICS, 2015, 8
[4]   Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait [J].
Albassam, Abdullah ;
Alshammari, Shahad ;
Ouda, Ghadeer ;
Koshy, Samuel ;
Awad, Abdelmoneim .
PLOS ONE, 2018, 13 (09)
[5]   An evaluation of the knowledge, opinions, expectations and concerns toward pharmacogenomics among Jordanian pharmacists [J].
AlEjielat, Rowan ;
Ejielat, Zeyad ;
Andrawes, Shireen ;
Mhaidat, Nizar M. .
PERSONALIZED MEDICINE, 2016, 13 (02) :143-154
[6]  
Aquilante CL., 2017, **DROPPED REF**, V37, pE202
[7]  
Awada Z, 2014, PHARMACOGENOMICS, V15, P845, DOI [10.2217/pgs.14.44, 10.2217/PGS.14.44]
[8]  
Bannur Z, 2014, INT MED J MALAYS, V13, P41
[9]   Precision Genetic and Genomic Medicine in the Middle East and North Africa Region: Are We There Yet? [J].
Bilani, Nadeem ;
Dagher, Michael ;
Zgheib, Nathalie K. .
PUBLIC HEALTH GENOMICS, 2017, 20 (03) :149-157
[10]   Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection [J].
Bousman, Chad A. ;
Zierhut, Heather ;
Muller, Daniel J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (02) :309-312